151 related articles for article (PubMed ID: 3931923)
21. Activity of ceftazidime and newer antibiotics against Gram-negative bacilli.
Schassan HH; Fedder J
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():79-82. PubMed ID: 19802973
[TBL] [Abstract][Full Text] [Related]
22. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
23. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
[TBL] [Abstract][Full Text] [Related]
24. A novel series of parenteral cephalosporins exhibiting potent activities against Pseudomonas aeruginosa and other Gram-negative pathogens: synthesis and structure-activity relationships.
Yamawaki K; Nomura T; Yasukata T; Uotani K; Miwa H; Takeda K; Nishitani Y
Bioorg Med Chem; 2007 Nov; 15(21):6716-32. PubMed ID: 17723304
[TBL] [Abstract][Full Text] [Related]
25. Antibacterial and antioxidant activities in Sideritis italica (Miller) Greuter et Burdet essential oils.
Basile A; Senatore F; Gargano R; Sorbo S; Del Pezzo M; Lavitola A; Ritieni A; Bruno M; Spatuzzi D; Rigano D; Vuotto ML
J Ethnopharmacol; 2006 Sep; 107(2):240-8. PubMed ID: 16690235
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
[TBL] [Abstract][Full Text] [Related]
27. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Fass RJ
Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
[TBL] [Abstract][Full Text] [Related]
28. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
29. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
30. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Jones RN; Sader HS; Fritsche TR
Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
[TBL] [Abstract][Full Text] [Related]
31. Determination of the postantibiotic effect of ofloxacin on gram-negative bacteria utilizing a new method.
Nilsson L; Isaksson B; Maller R; Nilsson M
J Chemother; 1989 Jul; 1(4 Suppl):149-51. PubMed ID: 16312347
[No Abstract] [Full Text] [Related]
32. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
Cluzel M; Chanal M; Sirot J; Cluzel R
Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
[TBL] [Abstract][Full Text] [Related]
33. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
Denis C; Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1984 May; 32(5):415-20. PubMed ID: 6429614
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli.
Sader HS; Jones RN
Int J Antimicrob Agents; 2005 Feb; 25(2):95-109. PubMed ID: 15664479
[TBL] [Abstract][Full Text] [Related]
35. [Non-fermentative Gram-negative bacilli of human origin. II. In vitro sensitivity of 185 strains to 17 anti-microbial agents].
Paredes L; Thompson L; del Canto E; Paredes L
Rev Med Chil; 1985 Sep; 113(9):878-85. PubMed ID: 3837315
[No Abstract] [Full Text] [Related]
36. In vitro activity of CI-934 and other antimicrobial agents against gram-positive and gram-negative bacteria.
Smith RP; Baltch AL; Hammer MC; Conroy JV
Clin Ther; 1986; 9(1):106-18. PubMed ID: 3815456
[TBL] [Abstract][Full Text] [Related]
37. Activity of ceftazidime against Gram-negative bacilli from paediatric patients.
Nelson JD; Shelton S
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():179-81. PubMed ID: 19802983
[TBL] [Abstract][Full Text] [Related]
38. [In vitro antimicrobial activity of CI-919 against gram-negative bacilli and Staphylococcus aureus isolated from various pathologies].
Prado V; Reyes L
Rev Med Chil; 1985 Feb; 113(2):94-102. PubMed ID: 3866270
[No Abstract] [Full Text] [Related]
39. A predictive parameter of antibacterial efficacy in vivo, based on efficacy in vitro and pharmacokinetics.
Mattie H
Scand J Infect Dis Suppl; 1990; 74():133-6. PubMed ID: 2129065
[TBL] [Abstract][Full Text] [Related]
40. In-vitro activity of cefepime and seven other antimicrobial agents against 1518 non-fermentative Gram-negative bacilli collected from 48 Canadian health care facilities. Canadian Afermenter Study Group.
Blondeau JM; Laskowski R; Borsos S
J Antimicrob Chemother; 1999 Oct; 44(4):545-8. PubMed ID: 10588318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
